Thrombotic events and prophylactic anticoagulation in pediatric patients with COVID-19: a systematic review and meta-analysis
CONCLUSIONS: The incidence of VTE in children with COVID-19 is low, and prophylaxis based on ISTH standards is reasonable. Low-molecular-weight heparin (LMWH) for VTE prevention has a high level of safety. However, more high-quality studies are needed to understand the impact of anticoagulant therapy on VTE incidence in pediatric patients with COVID-19.PMID:37961978 | DOI:10.1080/16078454.2023.2275912
Source: Hematology - Category: Hematology Authors: Di Xie Xiaoming Xue Wenxiao Qiao Jinyun Wang Lihong Meng Zhang Ye Dian Li Yaoqin Sun Source Type: research
More News: Bleeding | Children | Clinical Trials | COVID-19 | Databases & Libraries | Hematology | Men | Pediatrics | Study | Thrombosis